ASSUTA MEDICAL CENTERS LTD

Their core work

Assuta Medical Centers is Israel's largest private hospital network, operating across multiple locations with a strong focus on clinical services, diagnostics, and patient care. Within EU research, they contribute real-world clinical environments for testing personalized medicine tools — from breast cancer screening algorithms to chronic disease management platforms. Their role is typically as a clinical deployment and validation partner, bringing large patient populations and operational healthcare infrastructure to European consortia working on digital health and decision support systems.

What they specialise in

How they've shifted over time

Their early H2020 work (2016-2018) centered on patient self-management tools, activity monitoring, and genetics-based personalized screening — essentially equipping patients and clinicians with better data. By 2020-2021, the focus shifted decisively toward large-scale deployment of AI-powered integrated care platforms for chronic diseases like heart failure and frailty. The trajectory shows a clear move from pilot-stage personalized medicine toward operational, AI-enhanced care delivery at scale.

Assuta is moving from being a clinical trial site toward becoming an active deployment partner for AI-driven chronic disease management, making them increasingly relevant for projects needing real-world healthcare validation at scale.

How they like to work

Assuta operates exclusively as a participant or third party — never as coordinator — which is typical for a clinical partner contributing patient access and healthcare infrastructure rather than leading research design. With 64 unique partners across 13 countries, they integrate well into large European consortia. Their consistent presence in multi-partner health projects suggests they are a reliable clinical validation site that research consortia return to when they need real hospital environments outside the EU.

They have collaborated with 64 unique partners across 13 countries, indicating broad European reach despite being based in Israel. Their network spans clinical research institutions, universities, and digital health companies involved in personalized medicine and chronic care.

What sets them apart

As Israel's largest private hospital network, Assuta offers something rare in EU consortia: a non-EU clinical environment with high patient volumes, advanced medical infrastructure, and operational readiness for deploying digital health tools. Their private-sector agility combined with hospital-scale patient access makes them an attractive partner for projects that need rapid clinical validation outside traditional European academic hospitals. For consortium builders, they bring both credibility and a geographically diverse clinical site that strengthens proposals.

Highlights from their portfolio

• MyPeBS
  Their largest funded project (EUR 1.1M) and an ambitious international randomized study on personalized breast cancer screening using genetic risk stratification — running through 2027.
• TIQUE
  Their most recent project, combining AI with integrated care for heart failure and frailty — signals their strategic direction toward AI-enabled clinical services.
• CONNECARE
  Their entry point into H2020 connected care, establishing their role as a clinical deployment partner for chronic disease management platforms.